Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine.
In the last quarter of the year 2000, the meningococcal C conjugated vaccine was incorporated into the routine vaccination schedule in Catalonia (at 2, 4 and 6 months). In addition a vaccination campaign was carried out in children <6 years of age, with a coverage of 96.2%. The effectiveness of the vaccination in this age group during 2001 and the first 28 weeks of 2002 was 100% (94.27-100%). A vaccination campaign has been carried out in 6-19-year olds during 2001 and 2002, with a coverage rate of 23.5% in the year 2001. In this age group a reduction in disease incidence was seen in the 2000-2001 season, but not in the following one.
Salleras
L
L
Department of Health and Social Security, Generalitat of Catalonia, Travessera de les Corts, 131-159 Pavello Ave Maria, Barcelona 08028, Spain. dtorsalut@dsss.scs.es
Domínguez
A
A
Cardeñosa
N
N
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D032541:Mass Vaccination / Q000706:statistics & numerical data*; D008585:Meningitis, Meningococcal / Q000453:epidemiology*; D022401:Meningococcal Vaccines / Q000008:administration & dosage; D038542:Neisseria meningitidis, Serogroup C / Q000276:immunology*; D011634:Public Health; D013030:Spain / Q000453:epidemiology; D018074:Vaccines, Conjugate / Q000008:administration & dosage
D022401:Meningococcal Vaccines; D018074:Vaccines, Conjugate; C410218:serogroup C meningococcal conjugate vaccine